..

Dermatology and Dermatologic Diseases

ISSN: 2376-0427

Open Access
Editor-in-Chief

Hsuan-Hsiang Chen, Chief, Department of Dermatology
Jing-Mei General Hospital, Taiwan

Jean C Chamcheu, Director, Molecular Dermatology & Experimental Therapeutics Lab. University of Louisiana, School of Pharmaceutical & Toxicological Sciences, Monroe, USA

Iqbal A Bukhari, University of Dammam, Saudi Arabia

View Aims and Scope

About the Journal

NLM ID: 101694972

Index Copernicus Value: 61.93

The Dermatology and Dermatologic Diseases is a peer reviewed Journal that publishes studies based on skin, nails, hair and its diseases. It is the most appropriate arena for the mutual interaction between dermatologists, physicians and scientists interested in the skin, nails and hair biology around the world. The Dermatology and Dermatologic Diseases is an Open Access Scientific Journal that offers an interesting publishing platform globally and aims to keep scientists, clinicians and medical practitioners, researchers, and students informed and updated on the ongoing research in the relevant area. Outstanding quality articles are welcome to maintain the highest standard of the journal and to achieve high impact factor. Dermatology and Dermatologic Diseases is using Editorial Manager System for maintaining the quality in peer review process. Editorial Manager is an online manuscript submission, review and tracking system. Review processing is performed by the editorial board members of Dermatology and Dermatologic Diseases or by outside experts. At least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

Recent Articles

Recommended Conferences

Trauma, Emergency Medicine & Critical Care

Rome, Italy

Wound Care, Cell & Tissue Congress 2020

San Francisco, USA
 
arrow_upward arrow_upward